Literature DB >> 3472521

Urinary TGFs1 in neoplasia: immunoreactive TGF-alpha in the urine of patients with disseminated breast carcinoma.

K Stromberg, W R Hudgins, D N Orth.   

Abstract

A tumor-associated growth factor was identified in a 22-liter pool of urine from patients with disseminated breast cancer using an isolation scheme which separates transforming growth factor-alpha (TGF-alpha) from the high level of human epidermal growth factor (hEGF) normally present in urine. Concentration of urinary proteins by adsorption onto methyl bonded microparticulate silica, selective elution by acetonitrile, and subsequent gel permeation, cation exchange, and high performance liquid chromatography, resolved an EGF-related growth factor which generated a competitive binding curve similar to that of synthetic rat TGF-alpha in radioimmunoassay. A 26-liter pool of urine from normal subjects, evaluated in the same manner as a part of another study, did not contain measureable quantities of this factor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3472521     DOI: 10.1016/s0006-291x(87)80072-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Growth factor and sex steroid interactions in breast cancer.

Authors:  N J Kenney; R B Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

2.  Epidermal and transforming growth factor alpha in patients with breast tumours.

Authors:  H Gregory; C E Thomas; I R Willshire; J A Young; H Anderson; A Baildam; A Howell
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

3.  Growth factors in ovarian cancer.

Authors:  O J Owens; C Stewart; R E Leake
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.